These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension. Saji T; Ozawa Y; Ishikita T; Matsuura H; Matsuo N Am J Cardiol; 1996 Jul; 78(2):244-7. PubMed ID: 8712155 [TBL] [Abstract][Full Text] [Related]
5. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis]. Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653 [TBL] [Abstract][Full Text] [Related]
6. Treatment of pulmonary arterial hypertension. Humbert M; Sitbon O; Simonneau G N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304 [No Abstract] [Full Text] [Related]
7. Emerging therapies for pulmonary hypertension: striving for efficacy and safety. Kao PN; Faul JL J Am Coll Cardiol; 2003 Jun; 41(12):2126-9. PubMed ID: 12821235 [No Abstract] [Full Text] [Related]
8. Intravenous epoprostenol for primary pulmonary hypertension. Schulze-Neick I; Lange PE; Haas NA N Engl J Med; 1996 May; 334(22):1477; author reply 1477-8. PubMed ID: 8618596 [No Abstract] [Full Text] [Related]
9. Beraprost therapy in children with pulmonary hypertension secondary to congenital heart disease. Limsuwan A; Pienvichit P; Khowsathit P Pediatr Cardiol; 2005; 26(6):787-91. PubMed ID: 16132278 [TBL] [Abstract][Full Text] [Related]
10. Disproportionate pulmonary hypertension in a patient with early-onset pulmonary emphysema treated with specific drugs for pulmonary arterial hypertension. Shimizu M; Imanishi J; Takano T; Miwa Y Intern Med; 2011; 50(20):2341-6. PubMed ID: 22001462 [TBL] [Abstract][Full Text] [Related]
11. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis. Menon N; McAlpine L; Peacock AJ; Madhok R Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575 [TBL] [Abstract][Full Text] [Related]
12. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension]. Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506 [TBL] [Abstract][Full Text] [Related]
13. Marked improvement with sildenafil in a patient with primary pulmonary hypertension unresponsive to epoprostenol. Kataoka M; Satoh T; Manabe T; Anzai T; Yoshikawa T; Mitamura H; Ogawa S Intern Med; 2004 Oct; 43(10):945-50. PubMed ID: 15575245 [TBL] [Abstract][Full Text] [Related]
17. Beneficial hemodynamic effects of oral prostacyclin (PGI2) analogue, beraprost sodium, on a patient with primary pulmonary hypertension--a case report. Hashida H; Hamada M; Shigematsu Y; Ikeda S; Kuwahara T; Kawakami H; Hara Y; Kodama K; Kohara K; Hiwada K Angiology; 1998 Feb; 49(2):161-4. PubMed ID: 9482517 [TBL] [Abstract][Full Text] [Related]
18. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. McLaughlin VV; Genthner DE; Panella MM; Rich S N Engl J Med; 1998 Jan; 338(5):273-7. PubMed ID: 9445406 [TBL] [Abstract][Full Text] [Related]
19. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation. Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683 [TBL] [Abstract][Full Text] [Related]
20. Pulmonary arterial hypertension in a Kartagener syndrome patient: treatment with beraprost sodium. Shen YC; Wen FQ; Yi Q Int J Cardiol; 2012 Aug; 159(1):e9-10. PubMed ID: 22104985 [No Abstract] [Full Text] [Related] [Next] [New Search]